New Test of “Smart Bomb” Drug: A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer

GCF board member Dr. James Ford will be managing the Northern California trial site for a major international study in gastric cancer of a new drug from Roche’s Genentech unit.